Showing results (21-30 of 518) with videos related to

Sort By:
Pageof 52
International Journal of Cancer|March 15, 1994
Expression of cytokine/growth factors and their receptors in human melanoma and melanocytesS Mattei, M P Colombo, C Melani, et al.
Melanoma Research|September 1, 1992
Expression of cytokine genes, including IL-6, in human malignant melanoma cell linesM P Colombo, C Maccalli, S Mattei, et al.
International Journal of Cancer|October 15, 1990
Modulation of multidrug resistance by verapamil or mdr1 anti-sense oligodeoxynucleotide does not change the high susceptibility to lymphokine-activated killers in mdr-resistant human carcinoma (LoVo) lineL Rivoltini, M P Colombo, R Supino, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 23, 2006
Opposite immune functions of GM-CSF administered as vaccine adjuvant in cancer patientsG Parmiani, C Castelli, L Pilla, et al.
Cancer Research|May 15, 1995
Down-regulation of interleukin 6 receptor alpha chain in interleukin 6 transduced melanoma cells causes selective resistance to interleukin 6 but not to oncostatin MA Silvani, G Ferrari, G Paonessa, et al.
Natural Immunity and Cell Growth Regulation|January 1, 1991
Adjuvant adoptive immunotherapy with IL2 and lymphocytes from tumor-bearing mice: in vitro tumor-stimulated lymphocytes are more effective than LAK cellsM Rodolfo, C Salvi, C Bassi, et al.
International Journal of Cancer|April 22, 1993
In vitro anti-tumor activity of eosinophils from cancer patients treated with subcutaneous administration of interleukin 2. Role of interleukin 5L Rivoltini, V Viggiano, S Spinazzè, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1992
Granulocyte colony-stimulating factor (G-CSF) gene transduction in murine adenocarcinoma drives neutrophil-mediated tumor inhibition in vivo. Neutrophils discriminate between G-CSF-producing and G-CSF-nonproducing tumor cellsM P Colombo, L Lombardi, A Stoppacciaro, et al.
The Journal of Experimental Medicine|April 1, 1991
Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivoM P Colombo, G Ferrari, A Stoppacciaro, et al.
International Journal of Cancer|March 12, 1991
The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotypeL Rivoltini, G Cattoretti, F Arienti, et al.
Pageof 52